Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on the immunogenicity of Hepatitis B vaccination in patients on hemodialysis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Suping Wang | Conditions: Hepatitis B Vaccine | Phase 4 | Status: COMPLETED | Results posted: 2022-02-14